Tag: results were described in an article published last September 22 in the MedRxiv preprints website

Preliminary studies: Brazil’s Butanvac vaccine is safe and generates immune response

The Rio Times -
RIO DE JANEIRO, BRAZIL - Phase 1 clinical trials conducted in Thailand have shown that the Butanvac, a new Covid-19 vaccine candidate developed by the São Paulo state-owned Butantan Institute, is safe and has a powerful immunogenicity. The results...
Read more

LATEST NEWS

WEATHER

Rio de Janeiro
few clouds
33.2 ° C
35.1 °
32.2 °
56 %
4.1kmh
20 %
Mon
33 °
Tue
32 °
Wed
31 °
Thu
30 °
Fri
29 °
The Rio Times
The Rio Times is an English language publication dedicated to anyone interested in Brazil and Mercosur. Beyond keeping up with national and local events, The Rio Times will also cover issues of specific interest to foreign nationals here. Our mission is to provide our readers with a broad spectrum of information and improve their understanding of Rio de Janeiro, São Paulo, Brazil, and Mercosur.
Contact us: [email protected]

POPULAR POSTS

Popular Posts

POPULAR CATEGORY

© Copyright 2021 , The Rio Times/The Brazil News Agency, Inc.